|
437 National
service specification for EHC published The national template
service specification for pharmacy-based emergency hormonal contraception
(EHC) services was published last week
PJ 2006;277:437
Full Text
437 Benchmark
prices for enhanced services may save time and resources Publication
of national benchmark prices for core elements of enhanced services in
England may help to save time and resources currently spent on negotiating
prices locally
PJ 2006;277:437
Full Text
437 Royal Pharmaceutical
Society guidance on over-the-counter supply of simvastatin could help identify
high-risk patients Royal Pharmaceutical Society guidance on over-the-counter
sale of simvastatin goes beyond requirements set out by the Medicines and Healthcare
products Regulatory Agency for pharmacy supply and could help identify high-risk
patients who could otherwise be missed, according to Sadia Khan, lead pharmacist
for self care at the Society
PJ 2006;277:437
Full Text
437 Commissioning guidance
for England launched by NICE The first in a series of guides on how
to commission routine evidence-based services was launched this week by the National
Institute for Health and Clinical Excellence. It focuses on upper gastrointestinal
endoscopy services but other planned guides will address anticoagulation therapy
services, services for patients with chronic obstructive pulmonary disease and
diabetes foot care services
PJ 2006;277:437
Full Text
438 DTBcondemns brand extensions Tactics
used by pharmaceutical manufacturers to extend the profitability of their branded
products are thwarting prescribers' efforts to save the NHS money, the Drug and
Therapeutics Bulletin warned last week
PJ 2006;277:438
Full Text
438 Pharmacists can help
GPs earn QOF points Pharmacists could play a key role in helping GPs
achieve maximum points in the Quality and Outcomes Framework (QOF), the reward
scheme for practices under the new general medical services contract
PJ 2006;277:438
Full Text
438 EMEA budget cuts threaten
the protection of public health Threatened budget cuts will put the
public health functions of the European Medicines Agency (EMEA) at risk next
year, it says
PJ 2006;277:438
Full Text
439 Data
on England's public health reveal challenges A document setting out
the Government's approach to improving public health in England was published
earlier this week along with a report of detailed data on the nation's health,
as recorded in 2004
PJ 2006;277:439
Full Text
439 Conservative party
leader proposes independent board for NHS Conservative leader David
Cameron has promised to take the running of the NHS out of the hands of politicians
by setting up an independent board
PJ 2006;277:439
Full Text
439 Dedicated pharmacy
budgets needed in primary care, says IPF Primary care trusts must
have dedicated pharmacy budgets if community pharmacists are to be able to develop
their roles, the Independent Pharmacy Federation believes
PJ 2006;277:439
Full Text
440 GPs
worried about independent prescribing by pharmacists Doctors believe
that independent prescribing by nurses and pharmacists puts patients at risk,
according to a poll in GP newspaper Pulse
PJ 2006;277:440
Full Text
440 Prosecuting pharmacists
does not improve safety Charging pharmacists and doctors with manslaughter
after patients die as a result of medication errors is unlikely to improve patient
safety, researchers have concluded. They add that it will not do anything to
address the root causes of such mistakes either
PJ 2006;277:440
Full Text
440 Discount deductions
on unlicensed medicines Discount deduction exemptions can now be claimed
on unlicensed medicines sourced on a named-patient basis, the Pharmaceutical
Services Negotiating Committee has announced
PJ 2006;277:440
Full Text
440 Lloydspharmacy fighting £5m
damages case Lloydspharmacy is being sued for more than £5m by a US lawyer injured by steroids after one of the company's pharmacies dispensed what a doctor had prescribed
PJ 2006;277:440
Full Text
440 NHS trust ratings
published Annual health check ratings for all NHS trusts in England
were published by the Healthcare Commission this week
PJ 2006;277:440
Full Text
440 Resources available
for Ask About Medicines Week Posters, action packs and an information guide and directory are among the resources available to pharmacists who are planning activities for Ask About Medicines Week, which will run from 6–10 November
PJ 2006;277:440
Full Text
440 LPC template websites Template
websites for local pharmaceutical committees are now available
PJ 2006;277:440
Full Text
441 New
hepatitis B treatment approved for Scotland Entecavir (Baraclude),
a new treatment for hepatitis B infection, has been approved by the Scottish
Medicines Consortium in its latest round of appraisals
PJ 2006;277:441
Full Text
441 Scotland's prescription
volume grows Prescription volume continues to rise in Scotland, according
to the latest NHS statistics published last week
PJ 2006;277:441
Full Text
441 Shubao prosecution
follows pharmacist investigation A woman who sold a Chinese medicine
(Shubao) that contained a toxic derivative of fenfluramine has been successfully
prosecuted following a complaint from a pharmacist
PJ 2006;277:441
Full Text
441 New CCA chief executive Rob Darracott, currently director of corporate and strategic development at the Royal Pharmaceutical Society, is to take over from Colin Baldwin as chief executive of the Company Chemists' Association in February next year
PJ 2006;277:441
Full Text
441 Health minister visits
pharmacy research unit at RGU Lewis Macdonald, the Scottish Executive's deputy minister for health and community care, visited the newly refurbished research facilities at Robert Gordon University's school of pharmacy in Aberdeen last week
PJ 2006;277:441
Full Text
442 Oral
capecitabine-based regimen is as effective as infused 5-FU therapy in advanced
colorectal cancer Chemotherapy based on oral capecitabine is as effective
in terms of progression-free survival as the current standard treatment (infused
5-fluorouracil/leucovorin plus oxaliplatin) for advanced colorectal cancer and
requires far less infusion time, a study has shown
PJ 2006;277:442
Full Text
442 Pharmacist supplementary
prescribing in oncology highlighted A multidisciplinary oncology team,
which includes a pharmacist supplementary prescriber, has been praised this week
at the first P5 Excellence in Oncology Awards, organised by the British Oncological
Association
PJ 2006;277:442
Full Text
442 NICE’s donepezil,
galantamine and rivastigmine view stands The National Institute for
Health and Clinical Excellence's draft recommendation that donepezil, galantamine
and rivastigmine should only be used for patients with moderately severe Alzheimer's
disease will remain unchanged when its appraisal of Alzheimer's medicines is
published next month
PJ 2006;277:442
Full Text
442 Atypical antipsychotics
in Alzheimer’s disease investigated Side effects of atypical
antipsychotic drugs may limit any advantages they offer when treating psychosis,
aggression and agitation in Alzheimer's disease patients, a study published this
week suggests
PJ 2006;277:442
Full Text
442 Cancer medicines network A
network of experimental cancer medicine centres has been established, with a
funding boost of £35m from Cancer Research UK and the UK departments
of health
PJ 2006;277:442
Full Text |
The
Pharmaceutical Journal